FOR US RESIDENTS ONLY
Send Email  SEND TO A FRIEND   |   Print this page PRINT PAGE   |  A A A

CML Therapy Support
For Patients and
Caregivers

Building on a 5-year legacy of improvement in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), Novartis Oncology introduces CML Alliance, a unique support program designed to help optimize outcomes in Ph+ CML patients.

What is CML?

CML (chronic myeloid leukemia or chronic myelogenous leukemia) is a cancer of the blood and bone marrow (soft tissue within bones). Blood cells are made in the bone marrow.

How is CML Treated?

Chronic myelogenous leukemia (CML) is caused by a mutation that makes abnormal blood cells multiply and crowd out healthy ones. Treatment may block the signal that causes this growth.

The Importance of Staying on Course: Taking Your Treatment as Prescribed

Staying the course with daily treatment can be difficult, even when you know that it is important for your health. Fortunately, there are things that you can do to help yourself stay on track.

CMLearth
Connect with other
Ph+ CML patients
CMLearth